Use the ASMBS Corporate Council Search Function to locate Bariatric Resources

 

ALL COMPANIES

> EQUIPMENT
> CONSULTING
> & PROGRAM DEVELOPMENT

> SUPPLEMENTS
> INSURANCE
> PHARMACEUTICALS



 

 

 

 

 

 

 

Fleming Pharmaceuticals
1733 Gilsinn Lane
St. Louis County, Missouri 63026
tchole@flemingpharma.com

SERVICES:

CaloMist™

CATEGORY:

Supplements and Pharmaceuticals

CUSTOMERS:

B12 Deficient patients who are treated by RDs, RNs, and Nutritionists.

 

 

 

COMPANY DESCRIPTION:

Uncompromising quality, insistence on the highest standards, and a special relationship with the healthcare community endure today as pillars of Fleming's heritage. Specializing in the discovery, development, and manufacture of innovative prescription and over-the-counter (OTC) therapies, Fleming Pharmaceuticals is the proud maker of CaloMist TM, Magonate®, Nephrocaps®, the OCEAN® family of products, ThyroShield, and more.

Beginning in 1960, for more than four decades founder Tom Fleming’s talents in chemistry and physiology complemented his unique ability to develop new products based on his conceptual collaborations with physicians. Well known nationally in the medical community, Mr. Fleming remained active in the daily management of the company until his death in 2003. Today, second- and third-generation family members at the company carry on the founder’s legacy of innovation and creativity in pharmaceuticals R & D and manufacturing.
Fleming Pharmaceuticals concentrates on specific disease states and underserved clinical needs where the company’s core strengths and scientific expertise can best be leveraged. Bolstered by a strong commitment to science and the resources necessary for innovation, the R & D program provides the foundation for the discovery and development of breakthrough products to improve daily health and patient care. Fleming capabilities and agile processes enable the company to react quickly to evolving scientific strategies and market forces. Key areas of new product development focus include allergies, nasal delivery, nutrition, and topical care.

Fleming’s development strategy emphasizes growing market segments in strategically selected disease areas. Timely decision making and allocation of appropriate resources make Fleming an ideal partner for collaborations on product development and commercialization.

Based in the greater St. Louis area, privately held Fleming Pharmaceuticals has developed products for a variety of clinical conditions in allergy, pediatrics, nephrology, nutrition, and vitamin deficiency. The fully integrated Fleming headquarters facility houses state-of-the-art liquid, semi-solid and solid pharmaceutical manufacturing and packaging, analytical microbiological laboratories, research and development, distribution, marketing, and business administration functions.

CUSTOMER SERVICE INFORMATION:
Main Phone #: 636-343-5306
Alternative Phone #: 636-923-2500
Fax #: 636-343-5322

CONTACT INFORMATION:
Name: Tim Chole
Title/Position: Product Manager - Global Bariatrics
Phone #: 636-923-2554
Fax #: 636-923-5322
Email Address: tchole@flemingpharma.com

[About the ASMBS Corporate Council] [Corporate Council Members] [Corporate Council Benefits] [Corporate Council Application]

[ASMBS Homepage]